NCT02556736 - RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 14, 2015

Primary Completion Date

June 1, 2020

Study Completion Date

October 21, 2024

Conditions

Advanced Retinitis Pigmentosa

Interventions

DRUG

RST-001

RST-001 is a gene therapeutic delivered by intravitreal injection

Trial Locations (4)

Duke Eye Center, Durham

Cincinnati Eye Institute, Cincinnati

Retina Foundation of the Southwest, Dallas

University of California, San Francisco- Dept. of Ophthalmology, San Francisco